Photo of Kai Rejeski from X
May 9, 2024, 10:46
Kai Rejeski: All that we currently know and understand about CAR-T related cytopenias
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X:
“Check out our new review article in The Lancet Haematology: ‘Immune effector cell-associated hematotoxicity after CAR T-cell therapy: from mechanism to management’.
We summarize all that we currently know and understand about CAR-T related cytopenias.” .
Source: Kai Rejeski/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 6, 2025, 21:28
Sep 6, 2025, 20:34
Sep 6, 2025, 20:20
Sep 6, 2025, 20:00
Sep 6, 2025, 19:13
Sep 6, 2025, 19:01
Sep 6, 2025, 18:05